作者：
Banerji, Udai [1]
;
Dean, Emma J. [2]
;
Alejandro Perez-Fidalgo, J. [3]
;
Batist, Gerald [4]
;
Bedard, Philippe L. [5]
;
You, Benoit [6]
;
Westin, Shannon N. [7]
;
Kabos, Peter [8]
;
Garrett, Michelle D. [9]
;
Tall, Mathew [10]
;
Ambrose, Helen [11]
;
Barrett, J. Carl [12]
;
Carr, T. Hedley [13]
;
Cheung, S. Y. Amy ;
Corcoran, Claire ;
Cullberg, Marie ;
Davies, Barry R. ;
de Bruin, Elza C. ;
Elvin, Paul ;
Foxley, Andrew ;
Lawrence, Peter ;
Lindemann, Justin P. O. ;
Maudsley, Rhiannon ;
Pass, Martin ;
Rowlands, Vicky ;
Rugman, Paul ;
Schiavon, Gaia ;
Yates, James ;
Schellens, Jan H. M.
作者单位：
Univ Manchester, Med Oncol Drug Dev, Manchester, Lancs, England
[1]
Netherlands Canc Inst, Div Med Oncol, Amsterdam, Netherlands
[2]
Univ Colorado, Ctr Canc, Div Med Oncol, Aurora, CO USA
[3]
AstraZeneca, IMED, Cambridge, England
[4]
Princess Margaret Canc Ctr, Dept Med Oncol, Toronto, ON, Canada
[5]
Univ Lyon 1, Dept Med Oncol, Hosp Civils Lyon, Inst Cancerol,CITOHL, Lyon, France
[6]
Inst Canc Res, Clin Pharmacol & Trials, London, England
[7]
Hosp Clin Univ Valencia, Dept Oncol & Hematol, INCLIVA Biomed Res Inst, CIBERONC, Valencia, Spain
[8]
AstraZeneca, IMED, Waltham, MA USA
[9]
Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol & Reprod Med, Houston, TX 77030 USA
[10]
Inst Canc Res, Clin PD Biomarker Grp, Sutton, Surrey, England
[11]
McGill Univ, Jewish Gen Hosp, Segal Canc Ctr, Dept Oncol, Montreal, PQ, Canada
[12]
Univ Kent, Sch Biosci, Canterbury, Kent, England
[13]
发布时间
2019-04-18
换一批
